Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has maintained an 'Outperform' rating on Concentrix (NASDAQ:CNXC) but has lowered the price target from $84 to $70.
September 26, 2024 | 3:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barrington Research has maintained an 'Outperform' rating on Concentrix but has lowered the price target from $84 to $70, indicating a more cautious outlook.
The 'Outperform' rating suggests continued confidence in Concentrix's performance, but the lowered price target reflects a more cautious outlook, possibly due to market conditions or company-specific factors. This mixed signal may result in neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100